| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.33B | -41.9% |
| Cost of Revenue | $701.2M | -43.1% |
| Gross Profit | $629.1M | -40.6% |
| R&D Expense | $201.3M | -11.4% |
| SG&A Expense | $130.8M | -5.1% |
| Operating Income | $77.3M | -82.7% |
| Pre-tax Income | $120.2M | -76.6% |
| Income Tax | $17.5M | -76.4% |
| Net Income | $102.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $369.1M | +27.8% |
| Short-term Investments | $1.25B | -10.9% |
| Accounts Receivable | $223.7M | -49.8% |
| Inventory | $165.0M | -22.7% |
| Current Assets | $2.33B | -4.8% |
| Total Assets | $3.25B | -3.9% |
| Current Liabilities | $660.1M | +24.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $513.7M | -26.3% |
| Capital Expenditures | $33.6M | -69.6% |
| Investing Cash Flow | $128.3M | +135.0% |
| Financing Cash Flow | -$460.3M | +10.9% |
| Free Cash Flow | $480.1M | -18.1% |
| -76.6% |
| EPS (Basic) | $0.76 | -76.4% |
| EPS (Diluted) | $0.75 | -75.6% |
| Long-term Debt |
| $1.30B |
| +0.7% |
| Total Liabilities | $2.42B | +0.7% |
| Stockholders' Equity | $833.0M | -15.3% |